Nantahala Capital Management - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 134 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,389,250
-5.5%
440,031
+36.2%
0.55%
-16.5%
Q2 2023$6,763,195
-67.2%
323,134
-66.9%
0.65%
-58.6%
Q1 2023$20,606,890
-17.0%
975,7050.0%1.58%
-1.9%
Q4 2022$24,831,692
-26.5%
975,705
-30.6%
1.61%
-26.4%
Q3 2022$33,773,000
-34.1%
1,405,428
-47.2%
2.19%
-14.9%
Q2 2022$51,238,000
+9.5%
2,663,087
-1.1%
2.57%
+24.1%
Q1 2022$46,792,000
-29.9%
2,692,303
-11.7%
2.07%
-11.9%
Q4 2021$66,777,000
+31.5%
3,050,559
+14.8%
2.35%
+46.8%
Q3 2021$50,778,000
+14.0%
2,657,159
+2.5%
1.60%
+26.5%
Q2 2021$44,528,000
-0.5%
2,593,337
+29.5%
1.26%
-3.4%
Q1 2021$44,774,000
+11.9%
2,002,410
+11.3%
1.31%
+5.6%
Q4 2020$39,998,000
+102.4%
1,798,453
+34.3%
1.24%
+105.1%
Q3 2020$19,759,0001,338,6910.60%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,600,000$52,272,0008.55%
Foresite Capital Management IV, LLC 875,000$12,705,0007.06%
Aisling Capital Management LP 1,025,000$14,883,0006.13%
Saturn V Capital Management LP 807,969$11,731,7104.91%
Eversept Partners, LP 2,596,245$37,697,4773.19%
ACUTA CAPITAL PARTNERS, LLC 297,035$4,312,9482.89%
Paradigm Biocapital Advisors LP 2,390,077$34,703,9182.36%
DAFNA Capital Management LLC 458,373$6,655,5762.07%
SPHERA FUNDS MANAGEMENT LTD. 773,061$11,224,8462.04%
PFM Health Sciences, LP 2,715,235$39,425,2121.86%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders